Medical cannabis has been legal in the Czech Republic since 2013, with significant access expansion in 2022 when the specialist prescription requirement was removed. SÚKL manages import authorizations; MOH issues narcotic licenses. The Czech Republic is an active importing market with ~30,000+ patients and no significant domestic production. EU-GMP Part I is mandatory for all finished product imports.
Medical cannabis legal since 2013 under Act No. 378/2007 (Pharmaceutical Law). Initially limited access via specialist prescription. 2022 amendment removed specialist requirement — any licensed Czech physician may now prescribe. Growing patient base with ~30,000+ registered patients in 2026.
Licensing — Who Can Operate
Importers require a SÚKL wholesale dealer authorization and a Ministry of Health narcotic handling authorization. Pharmacies dispense under standard pharmacy licenses. No domestic cannabis production at scale — Czech Republic is a pure importing market.
Prescription Access
Any licensed Czech physician may prescribe since 2022. No approved indication list — physician discretion applies. Prescription on standard Czech prescription form. Health insurance does not reimburse cannabis — entirely out-of-pocket.
Magistral Preparation Pathway
Most cannabis in Czech Republic is dispensed as magistral preparations — pharmacies import cannabis drug substance and compound preparations per patient prescription. This simplifies the import authorization process (drug substance vs finished product).
Czech-Language Labeling Requirement
SÚKL requires Czech-language product labeling and a Czech-language summary of product characteristics for import authorization applications. This is commonly flagged as a deficiency — prepare Czech translations before submitting.
Key rule: SÚKL per-shipment import authorization required. EU-GMP Part I mandatory. Allow 3–6 weeks processing — longer than most EU peers. Czech-language labeling required.
SÚKL Import Authorization
Per-shipment import authorization from SÚKL. Applications include product specs, EU-GMP and GACP certificates, COA, and exporting country authorization. Processing: approximately 3–6 weeks. Czech-language documentation elements required.
Required Documentation
SÚKL import authorization (original), EU-GMP Part I certificate (cannabis scope), GACP certificate, COA per batch (QP signed), Exporting country export authorization, Airway bill, Czech-language product labeling.
Entry Points
Prague Václav Havel Airport (PRG) is the primary air entry point. Land border crossings relevant for road freight from Germany and Austria. Czech customs narcotic declaration under Single Convention 1961.
No Domestic Export
Czech Republic has no significant domestic cannabis production — it is an importing market only. No export authorization process currently relevant.
Key rule: EU-GMP Part I mandatory for all finished medicinal cannabis imports. SÚKL participates fully in EU GMP inspection network — all EEA authority certificates accepted directly.
EU-GMP Part I — Mandatory
All finished medicinal cannabis imported into Czech Republic must be manufactured under EU-GMP Part I. Certificate must be current and explicitly cover cannabis manufacturing scope. SÚKL rejects applications with expired or out-of-scope certificates.
Magistral Drug Substance Pathway
Cannabis drug substance (dried flower or extract) imported for pharmacy magistral preparation requires EU-GMP or equivalent for the manufacturing step, plus GACP for cultivation. The magistral preparation step in the pharmacy is covered by the pharmacy's own GMP-equivalent license.
Czech QP Batch Release
All finished product batches must be certified by an EU Qualified Person named on the Czech importer's wholesale authorization. For magistral drug substance, the QP certifies the drug substance batch before pharmacy compounding.
SÚKL Inspection Network
SÚKL participates in the EU GMP inspection network and shares inspection reports. EEA and PIC/S certificates (Israeli IMFA, TGA, Health Canada, MHRA) are accepted. SÚKL does not conduct separate GMP inspections of overseas sites for already EEA-certified manufacturers.
Note: SÚKL requires GACP certification for all cultivation sites. EU GACP and WHO GACP accepted. ISO 17065-accredited third-party certification required.
Accepted GACP Standards
SÚKL accepts EU GACP (EMEA/HMPC/246816/2006) and WHO GACP 2003. Certification by ISO 17065-accredited body required. Identical to all other EU member state requirements.
Certificate Requirements
Current GACP certificate required at time of SÚKL import authorization application. Certificate must name the specific cultivation site. 1–3 year validity. No grace period — SÚKL rejects applications with expired certificates.
Chain of Custody
GACP-to-GMP chain of custody must be documented. Any cultivation site change requires a new certificate and notification to SÚKL before continued import.
Cannabis Lawguidance
State Institute for Drug Control: Official News and Regulatory Updates
Accomplit SummaryThis document presents official announcements from the State Institute for Drug Control (SÚKL) concerning medicinal products and medical devices. It includes information on drug distribution suspensio...